Jump to main content
Jump to site search

Issue 20, 2012
Previous Article Next Article

Investigating cellular responses to novel chemotherapeutics in renal cell carcinoma using SR-FTIR spectroscopy

Author affiliations

Abstract

SR-FTIR spectroscopy was evaluated as a technique to discriminate spectral signals of cellular response at the single cell level, when cancer cells are exposed to chemotherapeutics. 5-Fluorouracil, an established drug of known mode of action, was tested against a renal carcinoma cell line (Caki-2), along with two experimental analogues of gold-based compounds. The use of unsupervised principal component analysis (PCA) failed to clearly define any distinction between control and drug treated cell spectra. Supervised principal component linear discriminant analysis (PC-LDA) did have some potential to reveal signatures of cell response and repair but again failed to distinctly discriminate groups of spectra with different drug treatments. Alternatively, clear PCA discrimination was observed in spectra from average cell populations via single point benchtop spectroscopy, probing several cells simultaneously with an increased aperture. The Caki-2 cell line initially appeared to be sensitive to the novel compounds, inducing a cellular response prior to subsequential cell recovery which was assessed by both PCA and cell viability assays.

Graphical abstract: Investigating cellular responses to novel chemotherapeutics in renal cell carcinoma using SR-FTIR spectroscopy

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 May 2012, accepted on 08 Aug 2012 and first published on 08 Aug 2012


Article type: Paper
DOI: 10.1039/C2AN35632E
Citation: Analyst, 2012,137, 4720-4726
  •   Request permissions

    Investigating cellular responses to novel chemotherapeutics in renal cell carcinoma using SR-FTIR spectroscopy

    C. Hughes, M. D. Brown, N. W. Clarke, K. R. Flower and P. Gardner, Analyst, 2012, 137, 4720
    DOI: 10.1039/C2AN35632E

Search articles by author

Spotlight

Advertisements